Stronger regulation needed to address injectable peptide craze

Tougher regulation on peptide supplies is needed as illegal use skyrockets among young Australians, University of Queensland researchers say. Dr. Timothy Piatkowski, of UQ's School of Public Health, said the country's regulatory ...

GLP-1 medication changes may support long-term weight management

Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn't switch, according to a new study by UT Southwestern ...

What's driving the obesity pandemic?

New research presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, (15โ€“17 July) asks what is driving the obesity pandemic.

page 9 from 40